Sodium Bicarbonate Nanoparticles for Amplified Cancer Immunotherapy by Inducing Pyroptosis and Regulating Lactic Acid Metabolism

Angew Chem Int Ed Engl. 2023 Oct 2;62(40):e202307706. doi: 10.1002/anie.202307706. Epub 2023 Aug 29.

Abstract

Although immunotherapy has a broad clinical application prospect, it is still hindered by low immune responses and immunosuppressive tumor microenvironment. Herein, a simple and drug-free inorganic nanomaterial, alkalescent sodium bicarbonate nanoparticles (NaHCO3 NPs), is prepared via a fast microemulsion method for amplified cancer immunotherapy. The obtained alkalescent NaHCO3 regulates lactic acid metabolism through acid-base neutralization so as to reverse the mildly acidic immunosuppressive tumor environment. Additionally, it can further release high amounts of Na+ ions inside tumor cells and induce a surge in intracellular osmolarity, and thus activate the pyroptosis pathway and immunogenic cell death (ICD), release damage-associated molecular patterns (DAMPs) and inflammatory factors, and improve immune responses. Collectively, NaHCO3 NPs observably inhibit primary/distal tumor growth and tumor metastasis through acid neutralization remitted immunosuppression and pyroptosis induced immune activation, showing an enhanced antitumor immunity efficiency. This work provides a new paradigm for lactic acid metabolism and pyroptosis mediated tumor treatment, which has a potential for application in clinical tumor immunotherapy.

Keywords: Immunosuppressive Tumor Microenvironment; Immunotherapy; Lactic Acid Metabolism; NaHCO3 Nanoparticle; Pyroptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Humans
  • Immunosuppressive Agents
  • Immunotherapy
  • Lactic Acid
  • Nanoparticles*
  • Neoplasms* / drug therapy
  • Pyroptosis
  • Sodium Bicarbonate / therapeutic use
  • Tumor Microenvironment

Substances

  • Lactic Acid
  • Sodium Bicarbonate
  • Immunosuppressive Agents